September 12, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Myelin Repair, Shape Changers, Misdiagnoses, and Virtual Reality Here is my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Breast Cancer Therapy, Tamoxifen, May Promote Myelin Repair in MS Remyelination could be a new role in MS therapy for a drug that has been used to treat breast cancer for some…
September 5, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Siponimod, Thymosin Patent, Orphan Drug, Lifestyle, and Lymphopenia Risk Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Gilenya-like Therapy Shows Benefit in Secondary Progressive MS Patients in Phase 3 Trial Here’s a potentially encouraging development for anyone with SPMS. Patients with secondary progressive multiple sclerosis (SPMS) who were treated with BAF312 (siponimod),…
August 29, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Umbilical Cells, Early Drugs, REAL Research, Hemoglobin, and Fatigue Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Umbilical Cord Blood-derived Cell Therapy Promotes Remyelination in Mice Now this is different, using umbilical cord stem cells. A cell therapy product derived from human umbilical cord blood cells may be…
August 15, 2016 News by admin MS Patient’s Pick of the Week’s News: Aggressive Therapies, Early MRIs, Tysabri and More Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Best First-Line Treatment for Aggressive MS May Be Equally Aggressive Immunotherapies Sounds like “Fight fire with fire” to me; could be just what is needed. Patients with aggressive onset multiple sclerosis, characterized…
August 8, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Antioxidant Therapies, Ocrevus, and Other Notables Here is my Pick of the Week’s News, from articles published on Multiple Sclerosis News Today. Antioxidant Therapies Seen as Promising Approach in Treating MS and Like Diseases Maybe antioxidant research could provide another avenue of MS therapy. A review article published in the British…
August 1, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Progressive Dwindling, Vitamin D, Disability Burdens, Talking with Doctors, and My MS Manager App Here’s my Pick of the Week’s News, from stories published on Multiple Sclerosis News Today. Nearly 75% of MS Patients in UK Study Went Through Progressive Decline Prior to Death Very few people living with MS or anyone close by affected by the disease can really…
July 25, 2016 Columns by admin BLOG: MS Patient’s Pick of the Week’s News: Nanobionic, Recruiting, Benign, Generic Danger, and ‘Inactive but Progressive’ Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Nanobionic Clothing Seen to Help Clear Body of Free Radicals Associated with MS and Other Diseases A recent study in the Journal of Medicinal Chemistry…
July 18, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Remyelination Drug Patent, Gut Microbiota, Statins, Cognition and Depression Quite a mixed bag in the pick of the week’s news: A drug in development, microbiota in the gut, statins and MS, DMTs and cognitive skills, and images of depression. Endece Granted New U.S. Patent for NDC-1308, Therapy to Induce Remyelination in MS This is a bit of an…
